Home    Resource Store    Past Issues    Buyers' Guide    Career Center    Subscriptions    Advertising    E-Newsletter    Contact

http://www.expoproduccion.mx/Content/Exhibitors/24/
http://www.textileservicesonline.com
http://www.spgprints.com
http://www.textileworld.com/partners/Shaffer_and_Max-Dyeing_and_Finishing_Plant_2014
http://ahweb.adsale.com.hk/t.aspx?unt=2396-ZhejiangTex14_TextileWorld
http://www.allstatestextile.com
http://ahweb.adsale.com.hk/t.aspx?unt=2354-STX15_TextileWorld
http://www.thiestextilmaschinen.com
July/August 2014 July/August 2014

View Issue  |

Subscribe Now  |

Events

7 International Specialized Exhibition of Fashion, Textile and Equipment (7 Textile EXPO)
07/22/2014 - 07/25/2014

Colombiamoda 2014 + Textiles2
07/22/2014 - 07/24/2014

Texworld USA/International Apparel Sourcing Show/Home Textiles Sourcing Expo
07/22/2014 - 07/24/2014

- more events -

- submit your event -

Printer Friendly
Full Site
Fiber World

DSM Unveils New Dyneema Purity® Biomedical Grade

The Netherlands-based DSM Dyneema has developed Dyneema Purity® TG dtex 25 TS180, a smaller-diameter grade of the high-performance, ultrastrong polyethylene fiber for biomedical applications that provides the same level of strength as existing grades.

Targeted for use in smaller, lower-profile biomedical implants for minimally invasive surgical procedures that can reduce scarring and shorten recuperation times, the new ISO-certified grade offers very high tensile strength as well as pliability, smoothness, fatigue and abrasion resistance, and a low friction coefficient, according to the company.

“Today’s minimally invasive procedures demand new instruments, technologies and materials, particularly thinner and smaller surgical devices and implants,” said Carina Snijder, business manager medical. “DSM is playing an important role in developing and improving advanced materials that allow medical device companies to develop more minimally invasive procedures. Building on our success with Dyneema Purity in ultrastrong orthopedic implants, we are expanding our portfolio by targeting cardiovascular applications, among others.”

May/June 2008

Advertisement